Effect of Abnormal Savda Munziq on Hypertrophic Scar Formation in A Rabbit Ear Model

Objective: To investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of diseases, affects hypertrophic scar (HTS) formation by using an established rabbit ear model. Methods: The HTS rabbit model was created by ci...

Full description

Saved in:
Bibliographic Details
Published inChinese journal of integrative medicine Vol. 21; no. 7; pp. 537 - 541
Main Author 王虎军 高伟成 马少林
Format Journal Article
LanguageEnglish
Published Beijing Chinese Association of Traditional and Western Medicine 01.07.2015
Subjects
Online AccessGet full text
ISSN1672-0415
1993-0402
1993-0402
DOI10.1007/s11655-014-1622-4

Cover

Abstract Objective: To investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of diseases, affects hypertrophic scar (HTS) formation by using an established rabbit ear model. Methods: The HTS rabbit model was created by circular full- thickness skin excisions on both ears of rabbits. Twenty rabbits were randomized into four groups, with 5 rabbits and 60 wounds in each group. Group A was the control group, treated with normal saline daily. Groups B, C, and D were the treatment groups at three different doses of ASMq (400, 800, and 1200 mg/kg body weight, respectively, daily, by gastrogavage). Twenty wounds were randomly chosen from each group on the 40th day after treatment and specimen were examined. Scar elevation index (SEI) was analyzed with histological assessment, and ultrastructure analysis was analyzed with a transmission electron microscopy. Results: Groups B, C, and D demonstrated significant reductions in SEI as compared with the control group at 35.9% (P=0.0212), 48.2% (P=0.0108), and 52.7% (P=0.0103), respectively in a dose-response manner. SEI was lowered in Group D compared with Group B with a significant difference (P=0.015). However, there were no significant differences between Groups B and C, or between Groups C and D. Histological analysis showed that high- dose ASMq (1200 mg/kg) could enhance the softening of HTS of rabbit ears and increase the compliance as shown in general. Ultrastructure analysis showed that with increased ASMq dose, the fibroblasts, pro-collagen, collagen, endoplasmic reticulum and ribosomes were reduced gradually. Conclusions: Orally administered ASMq significantly reduces the severity of HTS in the rabbit ear model. The findings of this study may have clinical implications on the management of human HTS.
AbstractList Objective To investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of diseases, affects hypertrophic scar (HTS) formation by using an established rabbit ear model. Methods The HTS rabbit model was created by circular fullthickness skin excisions on both ears of rabbits. Twenty rabbits were randomized into four groups, with 5 rabbits and 60 wounds in each group. Group A was the control group, treated with normal saline daily. Groups B, C, and D were the treatment groups at three different doses of ASMq (400, 800, and 1200 mg/kg body weight, respectively, daily, by gastrogavage). Twenty wounds were randomly chosen from each group on the 40th day after treatment and specimen were examined. Scar elevation index (SEI) was analyzed with histological assessment, and ultrastructure analysis was analyzed with a transmission electron microscopy. Results Groups B, C, and D demonstrated significant reductions in SEI as compared with the control group at 35.9% ( P =0.0212), 48.2% ( P =0.0108), and 52.7% ( P =0.0103), respectively in a dose-response manner. SEI was lowered in Group D compared with Group B with a significant difference ( P =0.015). However, there were no significant differences between Groups B and C, or between Groups C and D. Histological analysis showed that highdose ASMq (1200 mg/kg) could enhance the softening of HTS of rabbit ears and increase the compliance as shown in general. Ultrastructure analysis showed that with increased ASMq dose, the fibroblasts, pro-collagen, collagen, endoplasmic reticulum and ribosomes were reduced gradually. Conclusions Orally administered ASMq significantly reduces the severity of HTS in the rabbit ear model. The findings of this study may have clinical implications on the management of human HTS.
Objective: To investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of diseases, affects hypertrophic scar (HTS) formation by using an established rabbit ear model. Methods: The HTS rabbit model was created by circular full- thickness skin excisions on both ears of rabbits. Twenty rabbits were randomized into four groups, with 5 rabbits and 60 wounds in each group. Group A was the control group, treated with normal saline daily. Groups B, C, and D were the treatment groups at three different doses of ASMq (400, 800, and 1200 mg/kg body weight, respectively, daily, by gastrogavage). Twenty wounds were randomly chosen from each group on the 40th day after treatment and specimen were examined. Scar elevation index (SEI) was analyzed with histological assessment, and ultrastructure analysis was analyzed with a transmission electron microscopy. Results: Groups B, C, and D demonstrated significant reductions in SEI as compared with the control group at 35.9% (P=0.0212), 48.2% (P=0.0108), and 52.7% (P=0.0103), respectively in a dose-response manner. SEI was lowered in Group D compared with Group B with a significant difference (P=0.015). However, there were no significant differences between Groups B and C, or between Groups C and D. Histological analysis showed that high- dose ASMq (1200 mg/kg) could enhance the softening of HTS of rabbit ears and increase the compliance as shown in general. Ultrastructure analysis showed that with increased ASMq dose, the fibroblasts, pro-collagen, collagen, endoplasmic reticulum and ribosomes were reduced gradually. Conclusions: Orally administered ASMq significantly reduces the severity of HTS in the rabbit ear model. The findings of this study may have clinical implications on the management of human HTS.
To investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of diseases, affects hypertrophic scar (HTS) formation by using an established rabbit ear model. The HTS rabbit model was created by circular fullthickness skin excisions on both ears of rabbits. Twenty rabbits were randomized into four groups, with 5 rabbits and 60 wounds in each group. Group A was the control group, treated with normal saline daily. Groups B, C, and D were the treatment groups at three different doses of ASMq (400, 800, and 1200 mg/kg body weight, respectively, daily, by gastrogavage). Twenty wounds were randomly chosen from each group on the 40th day after treatment and specimen were examined. Scar elevation index (SEI) was analyzed with histological assessment, and ultrastructure analysis was analyzed with a transmission electron microscopy. Groups B, C, and D demonstrated significant reductions in SEI as compared with the control group at 35.9% (P=0.0212), 48.2% (P=0.0108), and 52.7% (P=0.0103), respectively in a dose-response manner. SEI was lowered in Group D compared with Group B with a significant difference (P=0.015). However, there were no significant differences between Groups B and C, or between Groups C and D. Histological analysis showed that highdose ASMq (1200 mg/kg) could enhance the softening of HTS of rabbit ears and increase the compliance as shown in general. Ultrastructure analysis showed that with increased ASMq dose, the fibroblasts, pro-collagen, collagen, endoplasmic reticulum and ribosomes were reduced gradually. Orally administered ASMq significantly reduces the severity of HTS in the rabbit ear model. The findings of this study may have clinical implications on the management of human HTS.
To investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of diseases, affects hypertrophic scar (HTS) formation by using an established rabbit ear model.OBJECTIVETo investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of diseases, affects hypertrophic scar (HTS) formation by using an established rabbit ear model.The HTS rabbit model was created by circular fullthickness skin excisions on both ears of rabbits. Twenty rabbits were randomized into four groups, with 5 rabbits and 60 wounds in each group. Group A was the control group, treated with normal saline daily. Groups B, C, and D were the treatment groups at three different doses of ASMq (400, 800, and 1200 mg/kg body weight, respectively, daily, by gastrogavage). Twenty wounds were randomly chosen from each group on the 40th day after treatment and specimen were examined. Scar elevation index (SEI) was analyzed with histological assessment, and ultrastructure analysis was analyzed with a transmission electron microscopy.METHODSThe HTS rabbit model was created by circular fullthickness skin excisions on both ears of rabbits. Twenty rabbits were randomized into four groups, with 5 rabbits and 60 wounds in each group. Group A was the control group, treated with normal saline daily. Groups B, C, and D were the treatment groups at three different doses of ASMq (400, 800, and 1200 mg/kg body weight, respectively, daily, by gastrogavage). Twenty wounds were randomly chosen from each group on the 40th day after treatment and specimen were examined. Scar elevation index (SEI) was analyzed with histological assessment, and ultrastructure analysis was analyzed with a transmission electron microscopy.Groups B, C, and D demonstrated significant reductions in SEI as compared with the control group at 35.9% (P=0.0212), 48.2% (P=0.0108), and 52.7% (P=0.0103), respectively in a dose-response manner. SEI was lowered in Group D compared with Group B with a significant difference (P=0.015). However, there were no significant differences between Groups B and C, or between Groups C and D. Histological analysis showed that highdose ASMq (1200 mg/kg) could enhance the softening of HTS of rabbit ears and increase the compliance as shown in general. Ultrastructure analysis showed that with increased ASMq dose, the fibroblasts, pro-collagen, collagen, endoplasmic reticulum and ribosomes were reduced gradually.RESULTSGroups B, C, and D demonstrated significant reductions in SEI as compared with the control group at 35.9% (P=0.0212), 48.2% (P=0.0108), and 52.7% (P=0.0103), respectively in a dose-response manner. SEI was lowered in Group D compared with Group B with a significant difference (P=0.015). However, there were no significant differences between Groups B and C, or between Groups C and D. Histological analysis showed that highdose ASMq (1200 mg/kg) could enhance the softening of HTS of rabbit ears and increase the compliance as shown in general. Ultrastructure analysis showed that with increased ASMq dose, the fibroblasts, pro-collagen, collagen, endoplasmic reticulum and ribosomes were reduced gradually.Orally administered ASMq significantly reduces the severity of HTS in the rabbit ear model. The findings of this study may have clinical implications on the management of human HTS.CONCLUSIONSOrally administered ASMq significantly reduces the severity of HTS in the rabbit ear model. The findings of this study may have clinical implications on the management of human HTS.
Author 王虎军 高伟成 马少林
AuthorAffiliation Department of Plastic Surgery of the First Teaching Hospital, Xinjiang Medical University, Urumqi 830054, China
Author_xml – sequence: 1
  fullname: 王虎军 高伟成 马少林
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24449084$$D View this record in MEDLINE/PubMed
BookMark eNp9kD1PHDEQhq2IKHzlB6SJrFQ0S_y96_KEjhAJFClAbXnXYzDas-_s3Ujk1-PLXSgoKEYeaZ53xnqO0UFMERD6Qsk5JaT9XihVUjaEioYqxhrxAR1RrXlDBGEHtVctqz2Vh-i4lCdCZKuI_IQOmRBCk04cobul9zBMOHm86GPKKzviW_vHWXwzx79hg1PEV89ryFNO68cw4NvBZny5BadQZyHiBf5t-z5MeFknN8nBeIo-ejsW-Lx_T9D95fLu4qq5_vXj58XiuhmEoFPDOQCDzrGBCAu67Rxvew-60xw0d8QqTWtp1_UOhLedJJYLJT14J1jX8hN0ttu7zmkzQ5nMKpQBxtFGSHMxVGlJO9IyUdGve3TuV-DMOoeVzc_mv4kK0B0w5FRKBv-KUGK2ts3Otqm2zda22WbaN5khTP-8TNmG8d0k2yVLvRIfIJunNOdYZb0b-rY_95jiw6bmXv-olBSMaUb4C9ranQc
CitedBy_id crossref_primary_10_1038_srep27831
crossref_primary_10_2147_CCID_S489625
crossref_primary_10_3389_fsurg_2022_711094
crossref_primary_10_1080_2000656X_2020_1814312
crossref_primary_10_1016_j_indcrop_2022_115113
Cites_doi 10.1007/s00266-008-9276-x
10.1111/j.1365-2230.2007.02636.x
10.2119/molmed.2009.00153
10.2515/therapie:2004083
10.1097/PRS.0b013e3182865c3f
10.1097/PRS.0b013e31823aea10
10.1111/j.1472-8206.2005.00342.x
10.1007/s12079-013-0195-5
10.1631/jzus.B1200077
10.1111/j.1472-8206.2004.00249.x
10.1590/S0100-879X2011000500004
10.1007/s00266-006-0253-y
10.1007/s00403-010-1114-8
10.1111/j.1365-4632.2012.05704.x
10.1111/j.1524-475X.2007.00219.x
10.1016/j.mvr.2008.09.005
10.1016/j.fitote.2004.05.005
10.1016/j.mvr.2008.08.007
10.1093/ecam/nep059
10.3892/mmr.2013.1278
10.3748/wjg.v13.i22.3056
ContentType Journal Article
Copyright Chinese Association of the Integration of Traditional and Western Medicine and Springer-Verlag Berlin Heidelberg 2015
Copyright_xml – notice: Chinese Association of the Integration of Traditional and Western Medicine and Springer-Verlag Berlin Heidelberg 2015
DBID 2RA
92L
CQIGP
W91
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1007/s11655-014-1622-4
DatabaseName 中文期刊服务平台
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Effect of Abnormal Savda Munziq on Hypertrophic Scar Formation in A Rabbit Ear Model
EISSN 1993-0402
EndPage 541
ExternalDocumentID 24449084
10_1007_s11655_014_1622_4
665422920
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
29B
29~
2B.
2C~
2J2
2JN
2JY
2KG
2KM
2LR
2RA
2VQ
2~H
30V
36B
4.4
406
408
40D
40E
5GY
5VR
5VS
6NX
6PF
92F
92I
92L
93N
93R
95-
95.
95~
96X
AAAVM
AABHQ
AABYN
AAFGU
AAHNG
AAIAL
AAJKR
AAKSU
AANXM
AANZL
AARHV
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYFA
AAYIU
AAYQN
AAYTO
ABDZT
ABECU
ABFGW
ABFTV
ABHQN
ABJNI
ABJOX
ABKAS
ABKCH
ABMNI
ABMQK
ABNWP
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABWNU
ABXPI
ACAOD
ACBMV
ACBRV
ACBYP
ACGFS
ACHSB
ACHXU
ACIGE
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACSNA
ACTTH
ACUDM
ACVWB
ACWMK
ACZOJ
ADHIR
ADINQ
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEEQQ
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFAFS
AFLOW
AFNRJ
AFQWF
AFUIB
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGJBK
AGKHE
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BDATZ
BGNMA
CAG
CCEZO
CHBEP
CIEJG
COF
CQIGP
CS3
CSCUP
CW9
DDRTE
DNIVK
DPUIP
DU5
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
ESBYG
F5P
FA0
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GRRUI
HF~
HG6
HMJXF
HRMNR
HVGLF
HZ~
IJ-
IKXTQ
ITM
IWAJR
I~X
I~Z
J-C
JBSCW
JZLTJ
LLZTM
M4Y
MA-
NDZJH
NPVJJ
NQJWS
NU0
O9-
P9S
PF0
PT4
QOR
QOS
R89
R9I
ROL
RPX
RSV
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCL
SCLPG
SDH
SHX
SISQX
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
STPWE
SV3
SZ9
SZN
T13
T16
TCJ
TGQ
TSG
TT1
TUC
U2A
U9L
UG4
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
W91
WFFXF
WK8
YLTOR
Z7U
ZMTXR
ZOVNA
~A9
~WA
-SE
-S~
AACDK
AAJBT
AASML
AAXDM
AAYZH
ABAKF
ABQSL
ACDTI
ACPIV
AEFQL
AEMSY
AFBBN
AGQEE
AGRTI
AIGIU
CAJEE
H13
Q--
SJYHP
U1G
U5O
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ABRTQ
ID FETCH-LOGICAL-c441t-33ee2e8d2c04ae978d37bfe9893e93d0a691a699d8bde4fa850a3465fefd42873
IEDL.DBID AGYKE
ISSN 1672-0415
1993-0402
IngestDate Fri Jul 11 06:05:58 EDT 2025
Wed Feb 19 01:57:24 EST 2025
Tue Jul 01 01:08:58 EDT 2025
Thu Apr 24 23:04:10 EDT 2025
Fri Feb 21 02:35:54 EST 2025
Wed Feb 14 10:29:58 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Abnormal Savda Munziq
ultrastructure
hypertrophic scar
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c441t-33ee2e8d2c04ae978d37bfe9893e93d0a691a699d8bde4fa850a3465fefd42873
Notes 11-4928/R
hypertrophic scar, Abnormal Savda Munziq, ultrastructure
Objective: To investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of diseases, affects hypertrophic scar (HTS) formation by using an established rabbit ear model. Methods: The HTS rabbit model was created by circular full- thickness skin excisions on both ears of rabbits. Twenty rabbits were randomized into four groups, with 5 rabbits and 60 wounds in each group. Group A was the control group, treated with normal saline daily. Groups B, C, and D were the treatment groups at three different doses of ASMq (400, 800, and 1200 mg/kg body weight, respectively, daily, by gastrogavage). Twenty wounds were randomly chosen from each group on the 40th day after treatment and specimen were examined. Scar elevation index (SEI) was analyzed with histological assessment, and ultrastructure analysis was analyzed with a transmission electron microscopy. Results: Groups B, C, and D demonstrated significant reductions in SEI as compared with the control group at 35.9% (P=0.0212), 48.2% (P=0.0108), and 52.7% (P=0.0103), respectively in a dose-response manner. SEI was lowered in Group D compared with Group B with a significant difference (P=0.015). However, there were no significant differences between Groups B and C, or between Groups C and D. Histological analysis showed that high- dose ASMq (1200 mg/kg) could enhance the softening of HTS of rabbit ears and increase the compliance as shown in general. Ultrastructure analysis showed that with increased ASMq dose, the fibroblasts, pro-collagen, collagen, endoplasmic reticulum and ribosomes were reduced gradually. Conclusions: Orally administered ASMq significantly reduces the severity of HTS in the rabbit ear model. The findings of this study may have clinical implications on the management of human HTS.
WANG Hu-jun , GAO Wei-cheng, and MA Shao-lin (Department of Plastic Surgery of the First Teaching Hospital, Xinjiang Medical University, Urumqi 830054, China)
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 24449084
PQID 1695180724
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_1695180724
pubmed_primary_24449084
crossref_primary_10_1007_s11655_014_1622_4
crossref_citationtrail_10_1007_s11655_014_1622_4
springer_journals_10_1007_s11655_014_1622_4
chongqing_primary_665422920
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-07-01
PublicationDateYYYYMMDD 2015-07-01
PublicationDate_xml – month: 07
  year: 2015
  text: 2015-07-01
  day: 01
PublicationDecade 2010
PublicationPlace Beijing
PublicationPlace_xml – name: Beijing
– name: China
PublicationTitle Chinese journal of integrative medicine
PublicationTitleAbbrev Chin. J. Integr. Med
PublicationTitleAlternate Chinese Journal of Integrative Medicine
PublicationYear 2015
Publisher Chinese Association of Traditional and Western Medicine
Publisher_xml – name: Chinese Association of Traditional and Western Medicine
References Zhu, Ding, Shankowsky, Tredget (CR15) 2013; 7
Foley, Ehrlich (CR18) 2013; 131
Choi, Hwang (CR10) 2004; 75
Atiyeh (CR20) 2007; 31
Song, Bian, Lai, Chen, Zhao (CR17) 2011; 44
Wang, Liu, Qing, Lu (CR5) 2009; 77
Issa, Kassuga, Chevrand, Pires (CR16) 2013; 52
Verrecchia, Mauviel (CR19) 2007; 13
Upur, Yusup, Baudrimont, Umar, Berke, Yimit (CR13) 2011; 25
Gauglitz, Korting, Pavicic, Ruzicka, Jeschke (CR3) 2011; 17
Armour, Scott, Tredget (CR4) 2007; 15
Yusup, Upur, Umar, Berke, Yimit, Lapham (CR9) 2011; 2011
Ko, Kim, Zhao, Hong, Mustoe (CR14) 2012; 129
Deng, Zheng, Wan, Zhang, Ding, Mao (CR8) 2013; 7
Tang, Zhu, Liang, Bi, Hu, Chen (CR7) 2011; 303
Ren, Hu, Li, Jiang, Hu, Han (CR6) 2013; 14
Yusup, Upur, Baudrimont, Umar, Kader, Begaud (CR11) 2005; 19
Widgerow, Chait, Stals, Stals, Candy (CR1) 2009; 33
Upur, Yusup, Umar, Moore (CR21) 2004; 59
Qi, Xie, Pan, Xu, Li, Tang (CR2) 2008; 33
Yusup, Upur, Umar, Moore (CR12) 2004; 18
HT Ren (1622_CR6) 2013; 14
JH Ko (1622_CR14) 2012; 129
GG Gauglitz (1622_CR3) 2011; 17
EM Choi (1622_CR10) 2004; 75
F Verrecchia (1622_CR19) 2007; 13
AD Widgerow (1622_CR1) 2009; 33
XQ Wang (1622_CR5) 2009; 77
A Yusup (1622_CR9) 2011; 2011
A Yusup (1622_CR12) 2004; 18
BS Atiyeh (1622_CR20) 2007; 31
H Upur (1622_CR21) 2004; 59
H Upur (1622_CR13) 2011; 25
SH Qi (1622_CR2) 2008; 33
C Deng (1622_CR8) 2013; 7
A Armour (1622_CR4) 2007; 15
MC Issa (1622_CR16) 2013; 52
B Tang (1622_CR7) 2011; 303
Z Zhu (1622_CR15) 2013; 7
TT Foley (1622_CR18) 2013; 131
A Yusup (1622_CR11) 2005; 19
R Song (1622_CR17) 2011; 44
17576505 - Aesthetic Plast Surg. 2007 Sep-Oct;31(5):468-92; discussion 493-4
15351109 - Fitoterapia. 2004 Sep;75(6):557-65
23414164 - Int J Dermatol. 2013 Mar;52(3):367-70
19561161 - Evid Based Complement Alternat Med. 2011;2011:152015
20927486 - Mol Med. 2011 Jan-Feb;17(1-2):113-25
23504443 - J Cell Commun Signal. 2013 Dec;7(4):239-52
23629085 - Plast Reconstr Surg. 2013 May;131(5):1036-44
18955370 - Evid Based Complement Alternat Med. 2011;2011:251424
17589920 - World J Gastroenterol. 2007 Jun 14;13(22):3056-62
15559555 - Therapie. 2004 Jul-Aug;59(4):483-4
21240513 - Arch Dermatol Res. 2011 Oct;303(8):563-72
19048338 - Aesthetic Plast Surg. 2009 Jul;33(4):533-43
23338822 - Mol Med Rep. 2013 Mar;7(3):785-90
18838083 - Microvasc Res. 2009 Mar;77(2):204-11
18201262 - Clin Exp Dermatol. 2008 Mar;33(2):171-5
23463765 - J Zhejiang Univ Sci B. 2013 Mar;14(3):224-30
15312154 - Fundam Clin Pharmacol. 2004 Aug;18(4):471-6
17727469 - Wound Repair Regen. 2007 Sep-Oct;15 Suppl 1:S6-17
16011734 - Fundam Clin Pharmacol. 2005 Aug;19(4):465-72
21445528 - Braz J Med Biol Res. 2011 May;44(5):402-10
22286441 - Plast Reconstr Surg. 2012 Feb;129(2):252e-261e
References_xml – volume: 33
  start-page: 533
  year: 2009
  end-page: 543
  ident: CR1
  article-title: Multimodality scar management program.
  publication-title: Aesthetic Plast Surg
  doi: 10.1007/s00266-008-9276-x
– volume: 33
  start-page: 171
  year: 2008
  end-page: 175
  ident: CR2
  article-title: Effects of asiaticoside on the expression of Smad protein by normal skin fibroblasts and hypertrophic scar fibroblasts.
  publication-title: Clin Exp Dermatol
  doi: 10.1111/j.1365-2230.2007.02636.x
– volume: 25
  start-page: 14
  year: 2011
  end-page: 24
  ident: CR13
  article-title: Inhibition of cell growth and cellular protein, DNA and RNA synthesis in human Hepatoma (HepG2) cells by ethanol extract of abnormal Savda Munziq of traditional Uighur medicine.
  publication-title: Evid Based Complement Alternat Med
– volume: 17
  start-page: 113
  year: 2011
  end-page: 125
  ident: CR3
  article-title: Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies.
  publication-title: Mol Med
  doi: 10.2119/molmed.2009.00153
– volume: 59
  start-page: 483
  year: 2004
  end-page: 484
  ident: CR21
  article-title: Uighur traditional medicine syndrome of Abnormal Savda in men is associated with oxidative stress, which can be improved by Munziq and Mushil of Abnormal Savda.
  publication-title: Therapie
  doi: 10.2515/therapie:2004083
– volume: 131
  start-page: 1036
  year: 2013
  end-page: 1044
  ident: CR18
  article-title: Through gap junction communications, co-cultured mast cells and fibroblasts generate fibroblast activities allied with hypertrophic scarring.
  publication-title: Plast Reconstr Surg
  doi: 10.1097/PRS.0b013e3182865c3f
– volume: 129
  start-page: 252e
  year: 2012
  end-page: 261e
  ident: CR14
  article-title: HMG-CoA reductase inhibitors (Statins) reduce hypertrophic scar formation in a rabbit ear wounding model.
  publication-title: Plast Reconstr Surg
  doi: 10.1097/PRS.0b013e31823aea10
– volume: 19
  start-page: 465
  year: 2005
  end-page: 472
  ident: CR11
  article-title: Cytotoxicity of abnormal Savda Munziq aqueous extract in human hepatoma (HepG2) cells.
  publication-title: Fundam Clin Pharmacol
  doi: 10.1111/j.1472-8206.2005.00342.x
– volume: 7
  start-page: 239
  year: 2013
  end-page: 252
  ident: CR15
  article-title: The molecular mechanism of hypertrophic scar.
  publication-title: J Cell Commun Signal
  doi: 10.1007/s12079-013-0195-5
– volume: 14
  start-page: 224
  year: 2013
  end-page: 230
  ident: CR6
  article-title: Endostatin inhibits hypertrophic scarring in a rabbit ear model.
  publication-title: J Zhejiang Univ (Chin)
  doi: 10.1631/jzus.B1200077
– volume: 18
  start-page: 471
  year: 2004
  end-page: 476
  ident: CR12
  article-title: Protective effects of Munziq and Mushil of abnormal Savda to mitochondrial oxidative damage.
  publication-title: Fundam Clin Pharmacol
  doi: 10.1111/j.1472-8206.2004.00249.x
– volume: 44
  start-page: 402
  year: 2011
  end-page: 410
  ident: CR17
  article-title: Normal skin and hypertrophic scar fibroblasts differentially regulate collagen and fibronectin expression as well as mitochondrial membrane potential in response to basic fibroblast growth factor.
  publication-title: Braz J Med Biol Res
  doi: 10.1590/S0100-879X2011000500004
– volume: 2011
  start-page: 152015
  year: 2011
  ident: CR9
  article-title: Abnormal Savda Munziq, an herbal preparation of traditional Uighur medicine, may prevent 1,2-dimethylhydrazine-induced rat colon carcinogenesis.
  publication-title: Evid Based Complement Alternat Med
– volume: 13
  start-page: 3056
  year: 2007
  end-page: 3062
  ident: CR19
  article-title: Transforming growth factor-beta and fibrosis.
  publication-title: World J Gastroenterol
– volume: 31
  start-page: 468
  year: 2007
  end-page: 492
  ident: CR20
  article-title: Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods.
  publication-title: Aesthetic Plast Surg
  doi: 10.1007/s00266-006-0253-y
– volume: 303
  start-page: 563
  year: 2011
  end-page: 572
  ident: CR7
  article-title: Asiaticoside suppresses collagen expression and TGFbeta/ Smad signaling through inducing Smad7 and inhibiting TGF-betaRI and TGF-betaRII in keloid fibroblasts.
  publication-title: Arch Dermatol Res
  doi: 10.1007/s00403-010-1114-8
– volume: 52
  start-page: 367
  year: 2013
  end-page: 370
  ident: CR16
  article-title: Topical delivery of triamcinolone via skin pretreated with ablative radiofrequency: a new method in hypertrophic scar treatment.
  publication-title: Int J Dermatol
  doi: 10.1111/j.1365-4632.2012.05704.x
– volume: 7
  start-page: 785
  year: 2013
  end-page: 790
  ident: CR8
  article-title: Suppression of cell proliferation and collagen production in cultured human hypertrophic scar fibroblasts by Sp1 decoy oligodeoxynucleotide.
  publication-title: Mol Med Rep
– volume: 15
  start-page: S6
  year: 2007
  end-page: S17
  ident: CR4
  article-title: Cellular and molecular pathology of HTS: basis for treatment.
  publication-title: Wound Repair Regen
  doi: 10.1111/j.1524-475X.2007.00219.x
– volume: 77
  start-page: 204
  year: 2009
  end-page: 211
  ident: CR5
  article-title: Hyperactivity of fibroblasts and functional regression of endothelial cells contribute to microvessel occlusion in hypertrophic scarring.
  publication-title: Microvasc Res
  doi: 10.1016/j.mvr.2008.09.005
– volume: 75
  start-page: 557
  year: 2004
  end-page: 565
  ident: CR10
  article-title: Antiinflammatory, analgesic and antioxidant activities of the fruit of Foeniculum vulgare.
  publication-title: Fitoterapia
  doi: 10.1016/j.fitote.2004.05.005
– volume: 77
  start-page: 204
  year: 2009
  ident: 1622_CR5
  publication-title: Microvasc Res
  doi: 10.1016/j.mvr.2008.08.007
– volume: 303
  start-page: 563
  year: 2011
  ident: 1622_CR7
  publication-title: Arch Dermatol Res
  doi: 10.1007/s00403-010-1114-8
– volume: 31
  start-page: 468
  year: 2007
  ident: 1622_CR20
  publication-title: Aesthetic Plast Surg
  doi: 10.1007/s00266-006-0253-y
– volume: 17
  start-page: 113
  year: 2011
  ident: 1622_CR3
  publication-title: Mol Med
  doi: 10.2119/molmed.2009.00153
– volume: 33
  start-page: 533
  year: 2009
  ident: 1622_CR1
  publication-title: Aesthetic Plast Surg
  doi: 10.1007/s00266-008-9276-x
– volume: 19
  start-page: 465
  year: 2005
  ident: 1622_CR11
  publication-title: Fundam Clin Pharmacol
  doi: 10.1111/j.1472-8206.2005.00342.x
– volume: 52
  start-page: 367
  year: 2013
  ident: 1622_CR16
  publication-title: Int J Dermatol
  doi: 10.1111/j.1365-4632.2012.05704.x
– volume: 131
  start-page: 1036
  year: 2013
  ident: 1622_CR18
  publication-title: Plast Reconstr Surg
  doi: 10.1097/PRS.0b013e3182865c3f
– volume: 59
  start-page: 483
  year: 2004
  ident: 1622_CR21
  publication-title: Therapie
  doi: 10.2515/therapie:2004083
– volume: 15
  start-page: S6
  year: 2007
  ident: 1622_CR4
  publication-title: Wound Repair Regen
  doi: 10.1111/j.1524-475X.2007.00219.x
– volume: 7
  start-page: 239
  year: 2013
  ident: 1622_CR15
  publication-title: J Cell Commun Signal
  doi: 10.1007/s12079-013-0195-5
– volume: 2011
  start-page: 152015
  year: 2011
  ident: 1622_CR9
  publication-title: Evid Based Complement Alternat Med
  doi: 10.1093/ecam/nep059
– volume: 25
  start-page: 14
  year: 2011
  ident: 1622_CR13
  publication-title: Evid Based Complement Alternat Med
– volume: 129
  start-page: 252e
  year: 2012
  ident: 1622_CR14
  publication-title: Plast Reconstr Surg
  doi: 10.1097/PRS.0b013e31823aea10
– volume: 14
  start-page: 224
  year: 2013
  ident: 1622_CR6
  publication-title: J Zhejiang Univ (Chin)
  doi: 10.1631/jzus.B1200077
– volume: 75
  start-page: 557
  year: 2004
  ident: 1622_CR10
  publication-title: Fitoterapia
  doi: 10.1016/j.fitote.2004.05.005
– volume: 33
  start-page: 171
  year: 2008
  ident: 1622_CR2
  publication-title: Clin Exp Dermatol
  doi: 10.1111/j.1365-2230.2007.02636.x
– volume: 7
  start-page: 785
  year: 2013
  ident: 1622_CR8
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2013.1278
– volume: 18
  start-page: 471
  year: 2004
  ident: 1622_CR12
  publication-title: Fundam Clin Pharmacol
  doi: 10.1111/j.1472-8206.2004.00249.x
– volume: 13
  start-page: 3056
  year: 2007
  ident: 1622_CR19
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v13.i22.3056
– volume: 44
  start-page: 402
  year: 2011
  ident: 1622_CR17
  publication-title: Braz J Med Biol Res
  doi: 10.1590/S0100-879X2011000500004
– reference: 23414164 - Int J Dermatol. 2013 Mar;52(3):367-70
– reference: 19048338 - Aesthetic Plast Surg. 2009 Jul;33(4):533-43
– reference: 18838083 - Microvasc Res. 2009 Mar;77(2):204-11
– reference: 23463765 - J Zhejiang Univ Sci B. 2013 Mar;14(3):224-30
– reference: 16011734 - Fundam Clin Pharmacol. 2005 Aug;19(4):465-72
– reference: 21240513 - Arch Dermatol Res. 2011 Oct;303(8):563-72
– reference: 15559555 - Therapie. 2004 Jul-Aug;59(4):483-4
– reference: 18955370 - Evid Based Complement Alternat Med. 2011;2011:251424
– reference: 23338822 - Mol Med Rep. 2013 Mar;7(3):785-90
– reference: 23504443 - J Cell Commun Signal. 2013 Dec;7(4):239-52
– reference: 18201262 - Clin Exp Dermatol. 2008 Mar;33(2):171-5
– reference: 17576505 - Aesthetic Plast Surg. 2007 Sep-Oct;31(5):468-92; discussion 493-4
– reference: 17727469 - Wound Repair Regen. 2007 Sep-Oct;15 Suppl 1:S6-17
– reference: 17589920 - World J Gastroenterol. 2007 Jun 14;13(22):3056-62
– reference: 22286441 - Plast Reconstr Surg. 2012 Feb;129(2):252e-261e
– reference: 20927486 - Mol Med. 2011 Jan-Feb;17(1-2):113-25
– reference: 15312154 - Fundam Clin Pharmacol. 2004 Aug;18(4):471-6
– reference: 15351109 - Fitoterapia. 2004 Sep;75(6):557-65
– reference: 21445528 - Braz J Med Biol Res. 2011 May;44(5):402-10
– reference: 19561161 - Evid Based Complement Alternat Med. 2011;2011:152015
– reference: 23629085 - Plast Reconstr Surg. 2013 May;131(5):1036-44
SSID ssj0057605
Score 2.030677
Snippet Objective: To investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of...
Objective To investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of...
To investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of diseases,...
SourceID proquest
pubmed
crossref
springer
chongqing
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 537
SubjectTerms Animals
Cicatrix, Hypertrophic - drug therapy
Cicatrix, Hypertrophic - pathology
Disease Models, Animal
Drugs, Chinese Herbal - pharmacology
Drugs, Chinese Herbal - therapeutic use
Ear - pathology
Female
Medicine
Medicine & Public Health
Original Article
Plant Extracts - pharmacology
Plant Extracts - therapeutic use
Rabbits
Wound Healing - drug effects
兔耳
增生性瘢痕
异常
微结构分析
成熟
超导模型
透射电子显微镜分析
高温超导
Title Effect of Abnormal Savda Munziq on Hypertrophic Scar Formation in A Rabbit Ear Model
URI http://lib.cqvip.com/qk/86437A/201507/665422920.html
https://link.springer.com/article/10.1007/s11655-014-1622-4
https://www.ncbi.nlm.nih.gov/pubmed/24449084
https://www.proquest.com/docview/1695180724
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3JbtswEB00DlD0knTP0gQs0FMLBVooiTwaQdKghXupDaQnghSp2mhA2bKcQ74-Q0m0kboNkINOpIYSh8sbvFkAPhm8ktrQLd3SjFrxgEldBgmjiZZK07BwjO7oR3Y1od-u0-s-jnvpvd09Jdme1JtgtyhLnaMZDaIMLSi6A7tpxDgbwO7w66_vF_4ARgTdei5GWR4HLgLdk5n_EuJSKkwr-3uBAz68mrbw5hZX2l5Bl_sw9h_feZ78OVs16qy4-yuv4xP_7iXs9ZCUDLs19AqeGfsano960v0NjLsMx6QqyVBZh3FvyE95qyUZrezdbEEqS6ZoztZNXc2ns4IsC1mTdVQkmVkiSS2VmjUE9xVpi--8hcnlxfj8KuiLMQQFIqYmSBJjYsN0XIRUGrQ9dZKr0nDEO4YnOpQZj_DhmiltaClZGsqEZmlpSu3MsuQdDGxlzQEQlblcSFSlimeUs5zrPJWlRLFG5czQQzhe60TMu6QbwlVJjl1prUMIvZZE0ecxd-U0bsQmA7ObS4FzKdxcChT4ef2Kl_dI549e9QK3muNPpDXVaontCEdZmMfY5323JtbiECU5ChVbvnj9iv40WP5_rKMn9T6GFwjX0s5Z-AMMmnplThASNeq03wKnsDOJh_dQZQA4
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NS8MwFA86Qb2I3875EcGTUujatE2PQ5Sp2y5usFtImtQNRrp1nQf_el_6sSFTwUNPSV8gL8n7PX7vA6FbBSYpT92SOc0oRWhRLmPLpcSVXEhiR4bR7fb89oC8DL1hmcc9r6LdK0oyf6lXyW5N3zOBZsRq-uBBkU20BViAmrYFA6dVPb-An_O4xaYfOJbJP6-ozJ9EmIIKo0S_z2C574ZpDW2uMaW5AXraR3slcsStQtUHaEPpQ7TdLbnxI9QvChHjJMYtoQ0UneA3_iE57i7053iGE41H4HWmWZpMR-MIzyOe4mXyIh5rzHHKhRhnGI4_znvkHKPB02P_oW2VPROsCIBNZrmuUo6i0olswhW4iNINRKxCgCUqdKXN_bAJXyipkIrEnHo2d4nvxSqWxntyT1BNJ1qdISx8U7KICE-EPglpEMrA4zEHsUoEVJE6aiw3j02L2hjMNDN2TAesOrKr7WRRWW7cdL2YsFWhZKMNBtpgRhsMBN4tf6nk_TH5ptIRgxthaA6uVbKYwzigRmoHDsw5LZS3FAdgxjCdMHJfaZOVl3b--1rn_5p9jXba_W6HdZ57rw20CwjLK-J7L1AtSxfqElBMJq7yU_sF8znlYA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1JSwMxFA4uIF7EfdcInpShs2S2Y1FLXVoELfQWkknGFkqmzkw9-Ot9ma1IVfAwp2ReIC8v-R7fWxC6lPAkFalboqAZBQ-NgInYcALiCMYFMSPN6Pb6XndAHobusOpzmtXR7jUlWeY06CpNKm9NRdyaJ75ZnquDzohheeBNkWW0CrexpQ_6wG7XVzFg6SKG0fJ829C56DWt-ZMIXVxhlKi3d1j6-yO1gDwXWNPiMepsoo0KReJ2qfYttCTVNlrrVTz5DnotixLjJMZtrjQsneAX9iEY7s3U5_gdJwqPwANN8zSZjsYRziKW4iaREY8VZjhlnI9zDKaAi345u2jQuXu96RpV_wQjApCTG44jpS0DYUcmYRLcReH4PJYhQBQZOsJkXmjBF4qAC0liFrgmc4jnxjIW2pNy9tCKSpQ8QJh7unwR4S4PPRIGfih8l8UMxEruB5IcouNm8-i0rJNBdWNjW3fDOkRmvZ00qkqP6w4YEzovmqy1QUEbVGuDgsCr5pda3h-TL2odUbAOTXkwJZNZBuOAIAPTt2HOfqm8RhwAG816wsh1rU1aGXD2-1pH_5p9jtaebzv06b7_eIzWAWy5ZajvCVrJ05k8BUCT87Pi0H4BWqvpnA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+Abnormal+Savda+Munziq+on+hypertrophic+scar+formation+in+a+rabbit+ear+model&rft.jtitle=Chinese+journal+of+integrative+medicine&rft.au=Wang%2C+Hu-jun&rft.au=Gao%2C+Wei-cheng&rft.au=Ma%2C+Shao-lin&rft.date=2015-07-01&rft.issn=1672-0415&rft.volume=21&rft.issue=7&rft.spage=537&rft_id=info:doi/10.1007%2Fs11655-014-1622-4&rft_id=info%3Apmid%2F24449084&rft.externalDocID=24449084
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F86437A%2F86437A.jpg